TREA

Karen Sommer

Follow

Person

  • Seattle, WA, US
People

Patents Grantslast 30 patents

  • Information Patent Grant

    Rapamycin resistant cells
    • Patent number 11,987,804
    • Issue date May 21, 2024
    • Seattle Children's Hospital
    • Andrew M. Scharenberg
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Expression of FOXP3 in edited CD34+ cells
    • Patent number 11,713,459
    • Issue date Aug 1, 2023
    • Seattle Children's Hospital
    • David J. Rawlings
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

  • Information Patent Application

    RAPAMYCIN RESISTANT CELLS
    • Publication number 20240294946
    • Publication date Sep 5, 2024
    • Seattle Children's Hospital (dba Seattle Children's Research Institute)
    • Andrew M. Scharenberg
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    EXPRESSION OF FOXP3 IN EDITED CD34+ CELLS
    • Publication number 20240117352
    • Publication date Apr 11, 2024
    • Seattle Children's Hospital (dba Seattle Children's Research Institute)
    • David J. Rawlings
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    ARTIFICIAL ANTIGEN-SPECIFIC IMMUNOREGULATORY T (AIRT) CELLS
    • Publication number 20230279351
    • Publication date Sep 7, 2023
    • Seattle Children's Hospital (dba Seattle Children's Research Institute)
    • Jane Buckner
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    RAPAMYCIN RESISTANT CELLS
    • Publication number 20210340573
    • Publication date Nov 4, 2021
    • Seattle Children's Hospital (dba Seattle Children's Research Institute)
    • Andrew M. Scharenberg
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    EXPRESSION OF HUMAN FOXP3 IN GENE EDITED T CELLS
    • Publication number 20210253652
    • Publication date Aug 19, 2021
    • Seattle Children's Hospital (dba Seattle Children's Research Institute)
    • Andrew M. Scharenberg
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    EXPRESSION OF FOXP3 IN EDITED CD34+ CELLS
    • Publication number 20210054376
    • Publication date Feb 25, 2021
    • Seattle Children's Hospital (dba Seattle Children's Research Institute)
    • David J. Rawlings
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    OPTIMIZED LENTIVIRAL VECTOR FOR XLA GENE THERAPY
    • Publication number 20200325458
    • Publication date Oct 15, 2020
    • Seattle Children's Hospital (dba Seattle Children's Research Institute)
    • David J. Rawlings
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE